Mira Pharmaceuticals (FRA:K6S) FCF Yield % : -42.52 (As of Jun. 25, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Mira Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Mira Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-4.18 Mil, and Market Cap is €9.90 Mil. Therefore, Mira Pharmaceuticals's FCF Yield % for today is -42.52%.

The historical rank and industry rank for Mira Pharmaceuticals's FCF Yield % or its related term are showing as below:

FRA:K6S' s FCF Yield % Range Over the Past 10 Years
Min: -46.81 Med: 0 Max: 0
Current: -42.52

FRA:K6S's FCF Yield % is ranked worse than
89.92% of 1081 companies
in the Drug Manufacturers industry
Industry Median: -0.16 vs FRA:K6S: -42.52

Mira Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Mira Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Mira Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mira Pharmaceuticals FCF Yield % Chart

Mira Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

FCF Yield %

Mira Pharmaceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial					-	-	-	-	-27.81

Competitive Comparison of Mira Pharmaceuticals's FCF Yield %

For the Drug Manufacturers - General subindustry, Mira Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mira Pharmaceuticals's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mira Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Mira Pharmaceuticals's FCF Yield % falls into.

Mira Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Mira Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-4.156	/	0
	=	N/A%

Mira Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.966	*	4	/	13.894046
	=	-27.81%

Mira Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Mira Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Mira Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mira Pharmaceuticals (FRA:K6S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mira Pharmaceuticals Inc (FRA:K6S) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

MIRA:USA

Address

855 N Wolfe Street, Suite 601, Baltimore, MD, USA, 21205

Website

https://www.mirapharmaceuticals.com

Mira Pharmaceuticals Inc is an early pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic THC analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. Its target patient population is also typically presenting with chronic pain. its drug candidate, MIRA1a, if approved by the FDA, maybe a significant advancement in the treatment of neuropsychiatric, inflammatory, and neurologic diseases and disorders. Based on pre-clinical and animal studies conducted by the company, it believes that MIRA1a enhances the therapeutic potential for treating anxiety, cognitive decline and chronic pain.

Mira Pharmaceuticals (FRA:K6S) Headlines

No Headlines